Benzinga | Mar 23, 2021 09:04AM EDT

Citius Pharmaceuticals To Highlight Its Phase 3 Clinical Trial Product Mino-Lok At Benzinga Biotech Small Cap Conference On March 25

Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (NASDAQ:CTXR), a specialty pharmaceutical company developing and commercializing critical care drug products, will participate in the virtual Benzinga Biotech Small Cap Conference being held March 24-25, 2021. Citius Executive Chairman, Leonard Mazur, will present on Thursday, March 25 at 2:55 pm ET. Investors may register for the conference at the event website.